For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20170807:nGNE8qmNr8
IQE plc ("IQE" or the "Company")
Director Dealings
Cardiff, UK. 7(th) August 2017: IQE plc has been informed by Dr Drew Nelson,
CEO, that he has transferred an aggregate of 1,000,000 ordinary shares of 1
pence each ("Ordinary Shares") to several family members on 4 August 2017 for
nil consideration (the "Transactions"). The family members are not deemed to
be closely associated persons ("PCA"). Dr Nelson's shareholding following
the transfer is 27,446,913 shares
Post the Transactions, Dr Nelson's total holding comprises of 28,459,218
Ordinary Shares (which includes 18,000,000 shares that are subject to an
obligation to repurchase as part of a loan agreement announced on 13 November
2014), representing 4.16% of the Company's issued share capital, and 3,145,433
unexercised fully vested options over Ordinary Shares. In addition, Dr Nelson
has 7,532,962 share options, which vest in January 2019 subject to performance
criteria.
The notification set out below is provided in accordance with the requirements
of the EU Market Abuse Regulation.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No.
596/2014
1. Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")
a) Name Dr Andrew Nelson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name IQE plc
b) Legal Entity Identifier 213800Y33WHD3ESJJP16
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument Ordinary shares of 1 pence each in the Company GB0009619924
b) Nature of the transaction Transfer of Ordinary Shares to non-PCA
c) Price(s) and volume(s) Price(s) Volume(s) Nil 500,000 Nil 500,000
d) Aggregated information * Aggregated volume 1,000,000 Ordinary Shares Nil cost
* Aggregated price
e) Date of the transaction(s) 4 August 2017
f) Place of the transaction London Stock Exchange, AIM
CONTACTS
IQE plc +44 (0) 29 2083 9400
Drew Nelson
Phil Rasmussen
Chris Meadows
Canaccord Genuity + 44 (0) 20 7523 8000
Simon Bridges
Henry Fitzgerald O'Connor
Richard Andrews
Peel Hunt +44 (0) 20 7418 8900
Euan Brown
This announcement is distributed by Nasdaq Corporate Solutions on behalf of
Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: IQE plc via Globenewswire